Latest News

TaskUs (NASDAQ:TASK) reported record third-quarter revenue and raised its full-year outlook, as growth in artificial intelligence services and customer experience work offset a decline in business from its largest client. Revenue rose 5.4% from a year earlier to $314.7 million, exceeding the top en

SiTime (NASDAQ:SITM) reported third-quarter revenue of $298.7 million, up 257% from a year earlier, as growth in its core timing business and the first full quarter of contributions from an acquired Renesas division pushed its annualized revenue run rate above $1 billion. The company forecast fourt

STAAR Surgical (NASDAQ:STAA) reported lower third-quarter sales and profit on a reported basis, but said revenue rose 21% after excluding a prior-year deferred sales item in China. The implantable lens maker also said demand for higher-priced products in China exceeded its ability to supply them dur

Silvaco Group (NASDAQ:SVCO) forecast record fourth-quarter revenue and mid-to-high teens revenue growth in 2027, as a major customer win helped drive third-quarter bookings for its technology computer-aided design products to a quarterly record. The company reported third-quarter revenue of $16.3 m

Revolution Medicines (NASDAQ:RVMD) reported $197.6 million in third-quarter net product revenue from its newly approved pancreatic cancer treatment RASONQUE, reflecting roughly five weeks of U.S. sales and treatment of more than 5,000 commercial patients. Executives cautioned that the initial sales

Root (NASDAQ:ROOT) reported a profit in the third quarter of 2026 even as revenue and premiums declined, with executives saying they held back spending on direct customer acquisition amid intensifying competition in personal auto insurance. The insurer generated $381 million in revenue, down from $

Rapid7 (NASDAQ:RPD) reported third-quarter annual recurring revenue above its guidance and reaffirmed its full-year cash flow outlook, but executives cautioned that stability in its core cybersecurity business has not yet translated into sustained growth. The company ended the quarter with $820 mil

Sunrun (NASDAQ:RUN) narrowed its full-year 2026 Cash Generation and subscriber value forecasts to the low ends of their previous ranges, citing installation volumes that have lagged its expectations and sustained higher interest rates. The residential solar and battery company now expects approxima

OPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale of BioReference assets to Labcorp. The transaction, announced Oct. 15, would provide approximately

Outset Medical (NASDAQ:OM) reported third-quarter 2026 revenue of $33.6 million, up 14% from a year earlier, as sales of its Tablo dialysis consoles increased and recurring revenue grew. The company reiterated its full-year revenue guidance of $125 million to $130 million. Revenue also rose 6% sequ

PROCEPT BioRobotics (NASDAQ:PRCT) reported 18% revenue growth in the third quarter of 2026 as demand for its HYDROS systems and procedure-related products helped offset slower-than-expected placements at new U.S. accounts. The company maintained its full-year revenue outlook and said it expects to

Sight Sciences (NASDAQ:SGHT) raised its full-year revenue outlook after reporting record third-quarter sales, driven by growth in its glaucoma business and increased adoption of its TearCare dry eye treatment. Revenue for the quarter ended September 30, 2026, rose 25% from a year earlier to $24.9 m

Woodside Energy Group (NYSE:WDS) outlined a new shareholder distribution policy and capital allocation framework at its 2026 Capital Markets Day, as the energy producer targets higher returns from major oil and liquefied natural gas projects. Chief Executive Officer and Managing Director Liz Westco

Power Integrations (NASDAQ:POWI) reported higher third-quarter revenue and earnings as demand for gallium nitride products and industrial applications offset weakness in appliances. The company also forecast fourth-quarter revenue growth from a year earlier, while cautioning that elevated channel in

Remitly Global (NASDAQ:RELY) reported record third-quarter revenue and adjusted earnings as customers sent more money through its network, while management outlined plans to invest in business payments and cards alongside its core remittance operations. Revenue rose 22% year over year to $510 milli

PureCycle Technologies (NASDAQ:PCT) reported lower third-quarter revenue after production problems at its Ironton plant and a New Jersey regulatory delay disrupted its sales plans. Management said the issues have been resolved, but the company no longer expects to reach its previously discussed prod

Precigen (NASDAQ:PGEN) reported $72.9 million in third-quarter 2026 sales of PAPZIMEOS, its treatment for adults with recurrent respiratory papillomatosis, as the company posted a second consecutive profitable quarter and generated positive cash flow ahead of its prior expectations. Sales of PAPZIM

Progyny (NASDAQ:PGNY) raised the midpoint of its full-year 2026 guidance after reporting record third-quarter revenue and profitability and securing a record 1.3 million new covered lives during its latest selling season. The fertility and family-building benefits company expects the majority of th

Red Violet (NASDAQ:RDVT) reported record third-quarter revenue and operating cash flow as demand for its identity intelligence services grew across its markets, though its IDI real estate business remained under pressure. Revenue rose 20% from a year earlier to $27.8 million, while operating cash f

Historically, stocks have soared in the third year of a presidential term.

The margin story rests on a 98% franchised target, and whether baseline traffic can carry that model through 2028 is still open.

Tens of thousands of cell sites start going up in 2027. How much of that belongs in the stock price now?

IonQ trades at a premium, while SoundHound AI shows a clearer path to profitability.

Intuitive Machines went flat for two years before tripling revenue, while Rocket Lab grew steadily -- but the gap is closing fast.

The chipmaker now expects its revenue to rise over 80% next year. What's a fair price to pay for that?